Dr Susan Costantini
National Cancer Institute "Giovanni Pascale Foundation", IRCCS
Novel technologies are leading to the identification of numerous biomarkers aimed to predict cancer progression and therapeutic treatment responses. The search for new prognostic and predictive biomarkers is the object of many studies performed on cells, blood samples, and tissues. However, only few cancer biomarkers have been inserted into clinical practice until now and for this reason it is important to run studies focused on this scientific field.
Submission deadline: 14/09/2024